Related Experiment Video
Updated: Jun 14, 2026
05:32
In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
Published on: February 16, 2024
Hematopoietic stem cell transplantation for osteopetrosis
1Department of Cellular & Molecular Medicine, School of Medical Sciences, University of Bristol, University Walk, Bristol, BS8 1TD, UK. colin.steward@bristol.ac.uk
Pediatric Clinics of North America
|March 24, 2010
Summary
Osteopetrosis, a group of rare genetic bone diseases, results from osteoclast dysfunction. Understanding the specific gene affected is crucial for determining prognosis and treatment, including stem cell transplantation.
Area of Science:
- Genetics
- Pediatrics
- Hematology
Background:
- Osteopetrosis encompasses a spectrum of inherited disorders characterized by impaired osteoclast activity.
- Disease severity ranges from lethal infantile forms to asymptomatic adult radiological findings.
Purpose of the Study:
- To review the diverse characteristics of osteopetrosis.
- To outline current and potential management strategies for osteopetrosis.
Main Methods:
- Literature review of osteopetrosis research.
- Analysis of genetic factors influencing disease presentation.
- Evaluation of therapeutic interventions.
Main Results:
- Osteoclast deficiency is the underlying cause of osteopetrosis.
- Genetic mutations dictate the variable severity and clinical course.
- Hematopoietic stem cell transplantation is a key therapeutic option for severe cases.
Conclusions:
- Accurate genetic diagnosis is essential for predicting osteopetrosis prognosis.
- Tailored management strategies, including transplantation, improve patient outcomes.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...